Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Februar 2019 14:07 ET | Quelle: 3-V Biosciences

Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing

HANGZHOU, China and SHAOXING, China and SAN FRANCISCO, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announce today...
04. November 2016 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences to Present Data at the American Association for the Study of Liver Diseases Annual Meeting 2016 in Boston, MA

MENLO PARK, CA--(Marketwired - Nov 4, 2016) - 3-V Biosciences, Inc., a clinical-stage pharmaceutical company developing therapeutics for liver diseases, including non-alcoholic steatohepatitis...
04. März 2016 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences Presents Data at Keystone Symposia Scientific Conference

MENLO PARK, CA--(Marketwired - Mar 4, 2016) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology, announced today that data from its ongoing Phase...
02. November 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences to Present Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, MA

MENLO PARK, CA--(Marketwired - Nov 2, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology, announced today that it will present three...
17. September 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences to Present Data at the 18th ECCO - 40th ESMO European Cancer Congress in Vienna

MENLO PARK, CA--(Marketwired - Sep 17, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology, announced today that it will present data from...
03. August 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences to Present at the 2015 Wedbush PacGrow Healthcare Conference on August 12, 2015

MENLO PARK, CA--(Marketwired - Aug 3, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics in oncology and infectious diseases, announced today that it...
09. Juni 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences Provides Clinical Update on TVB-2640 at AACR Metabolism and Cancer Conference

MENLO PARK, CA--(Marketwired - Jun 9, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious...
07. April 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences Announces Three Poster Presentations at the 2015 AACR Annual Meeting

MENLO PARK, CA--(Marketwired - Apr 7, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious...
24. Februar 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences to Present at the Cowen and Company 35th Annual Health Care Conference on March 4, 2015

MENLO PARK, CA--(Marketwired - Feb 24, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that focus on the role of fatty acid synthase (FASN) in...
19. Februar 2015 05:30 ET | Quelle: 3-V Biosciences

3-V Biosciences Appoints Rekha Hemrajani as Chief Financial Officer

MENLO PARK, CA--(Marketwired - Feb 19, 2015) - 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious...

Nächste Seite